German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorLudwig-Maximilians - University of Munich
About this trial
The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.
Eligibility criteria
Qualifiers
Medical appointment for dementia diagnostics at the Alzheimer Therapie- und Forschungszentrum
Provision of signed, written and dated informed consent
Capacity to give informed consent
Disqualifiers
dementia in a very advance stage
Illiteracy
Trial design
Treatments tested in this trial
- Subjective Cognitive Decline-Questionnaire (SCD-Q)
- Cognitive Failure Questionnaire (CFQ)
- biomarkers
- Cognitive Tests
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Ludwig-Maximilians - University of Munich
Lead sponsor
Medotrax UG
Collaborator
Source ClinicalTrials.gov